Work

13P The landscape of human epidermal growth factor receptor 2 (HER2) expression in gynaecologic tumors (GynT)

Year: 2026

Type: article

Abstract: HER2-targeted therapies have improved outcomes in multiple solid tumors and are under investigation in GynT, where reported HER2 expression is variable and, despite associations with aggressive disease, its clinical significance remains unclear.

Source: ESMO Open

DOI: 10.1016/j.esmoop.2026.108038

Authors: I. Giannubilo, R. Mazzeo, L. Carità, G. Villacampa, L. Fariñas Madrid, D. Garcia Illescas, D. Montanari, P.G. Nuciforo, J. Jimenez, R. Fasani, A. Oaknin, C. Garcia Duran

Institutions: Vall d'Hebron Institute of Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Hospital Universitario Puerta de Hierro Majadahonda

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,910

Funders: Instituto de Salud Carlos III, European Social Fund

Awards: Validación de herramientas diagnósticas OMICS para la identificación de dianas terapeúticas y monitoreo de la recurrencia en glioblastoma, G2704968376, Nanoterapia innovadora para cánceres peritoneales metastásicos: activando neuroreceptores para matar células madre tumorales

OpenAlex ID: W7167012732

FWCI:

Cites:

Cited by:

Related to: